|
⚲
|
| Keyboard |
| EPIQ Capital Group LLC
✚
|
|
|---|---|
| CRD # | 292526 |
| SEC # | 801-112887 |
| CIK # | 0001779453 |
| AUM | |
| Employees | 60 (53% Investors, 0% Brokers) |
| Phone | 415-433-3747 |
| Address | 1 Lombard St 200 San Francisco, CA 94111 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Reddit Inc | 26.7 | ||
| iShares Comex Gold Trust | 26.3 | ||
| Facebook Inc | 20.3 | ||
| SPDR Gold Trust | 16.8 | ||
| Rubrik Inc | 13.5 | ||
| Applovin Corp | 12.8 | ||
| Apple Inc | 4.5 | ||
| Alibaba Group Holding Ltd | 3.5 | ||
| JDcom Inc | 2.6 | ||
| Datadog Inc | 2.4 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | EPQ LLC DGNR VI PS | [2023-03-31] | 52.0 M | |
| Filed 2021-08-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Antios B PS | [2022-03-30] | ||
| Filed 2021-09-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Applvn PS | [2022-03-30] | ||
| Filed 2021-03-11 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Ltest PS | [2022-03-30] | ||
| Filed 2021-01-21 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Owlet PS | [2022-03-30] | ||
| Filed 2021-02-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Transform III PS | [2022-03-30] | 40.0 M | |
| Filed 2022-01-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC AMTC PS | [2021-03-30] | 35.0 M | 0.5 M |
| Offered $35,000,000 · Filed 2020-06-15 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Lcovd PS | [2021-03-30] | ||
| Filed 2020-07-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Lcovd Safe PS | [2021-03-30] | ||
| Filed 2020-11-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC LFLU PS | [2021-03-30] | 17.5 M | |
| Offered $17,500,000 · Filed 2020-01-14 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 234 | 2.8 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 86 | 2.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 896 | 4.9 |
| By Discretionary | ||
| Discretionary | 647 | 2.7 |
| Non-Discretionary | 249 | 2.3 |
| Total | 896 | 4.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.1 | |
| United States Persons | 4.9 | |
| Total | 896 | 4.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Epiq Capital Group LLC | Director | 110 | 3 | |
| Epiq Capital Group LLC | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001779453] | |
| 3 | [0001779453] | |
| 4 | [0001779453] | |
| 5 | [0001779453] | |
| SC 13D | [0001779453] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| EPIQ Capital Group LLC | Lucira Health Inc | [2021-02-12] |
| EPIQ Capital Group LLC | Applied Molecular Transport Inc | [2020-06-18] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional, Retail |
| Fund Types | Private Equity |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 293,278 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 2,149,292 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 3,394,948 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 2,500,000 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 3,461,764 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 735,475 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 725,675 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 3,754,084 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 5,173,026 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 256,742 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2022-05-13 | Buy | 29,763 | $4.17 | 124,112 |
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2022-05-12 | Buy | 32,380 | $3.88 | 125,634 |
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2021-11-17 | Buy | 7,135 | $22.38 | 159,681 |
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2021-11-16 | Buy | 4,000 | $22.57 | 90,280 |
|
Lucira Health Inc LHDX
Series B Convertible Preferred · derivative
|
2021-02-05 | Conversion | 32,176 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 735,475 | $17.00 | 12,503,075 |
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 3,754,084 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 32,176 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Buy | 3,461,764 | $17.00 | 58,849,988 |
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 5,173,026 | ||
| showing 20 of 45 most recent transactions | |||||